This post was originally published on this site
AbbVie announced earnings per share of $3.37 on revenue of $14.58B. Analysts polled by Investing.com anticipated EPS of $3.34 on revenue of $14.67B.
AbbVie shares are up 10% from the beginning of the year, still down 14.93% from its 52 week high of $175.91 set on April 8. They are outperforming the S&P 500 which is down 14.56% from the start of the year.
AbbVie shares gained 0.31% in pre-market trade following the report.
AbbVie’s report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
